Science Pool

Evotec announces progress in strategic protein degradation partnership with Bristol Myers Squibb

Evotec SE today announced progress within the Company’s strategic partnership with Bristol Myers Squibb relating to building a molecular glue-based pipeline. Performance-based and programme-based achievements trigger payments of in total US$ 75 m to Evotec.

Read More

Twitter
LinkedIn
Email